eli lilly trial retatrutide Retatrutide, Lilly's next generation of weight loss injections, showed dramatic results in clinical trials, with patients losing an average of up to 71.2 pounds, or 28.7% of their body weight. Eli Retatrutide vs Eloralintide Obesity Therapies

Well help you determine the right frequency and dosage to achieve your desired results, ensuring you get exactly what your body needs without any guesswork

Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-Transporter-2 Inhibitors as Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-Analysis

Park and Dilda, 2010)

But the 8mg dose produced 21.1% average weight loss in the same trial

Light Sensitivity: Keep the vials stored in darkness or within their original boxes, as prolonged ultraviolet (UV) exposure can degrade the delicate peptide bonds

And if you love how you feel, you can take some home with you